While you might not feel a jolt like caffeine, your cells are beginning to reset their metabolic processes
For clinicians and patients building a precision longevity protocol, the central question is no longer whether MOTS-c matters, but how to dose it correctly
83% of peptide-aware Americans want the FDA to make peptides more accessible Days before an FDA advisory committee meets to consider whether seven widely used peptides BPC-157, TB-500, KPV, MOTS-c, Emideltide (DSIP), Semax, and Epitalon should become eligible for compounding, a new survey suggests thats what Americans want
Discoveries from our labs or moving into the clinic to help us all live better, longer
Peluso MJ, Deveau TM, Munter SE, Ryder DM, Buck AM, Beck-Engeser G, et al